Dec 01, 2011 11:15 EST Uppsala, Sweden, December 1, 2011 – Halo Genomics today announced it has been acquired by Agilent Technologies Inc. (NYSE: A), the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications.
Tag: target enrichment
Nov 22, 2011 03:00 EST Halo Genomics AB, a company providing products for next generation targeted sequencing, today announced the appointment of D-MARK Biosciences as its distributor in Canada.
Oct 25, 2011 03:00 EDT Halo Genomics AB, a company providing products for next generation targeted resequencing, has strengthened its sales organization and established a sales office in Cambridge, MA
Nov 09, 2011 12:32 EST
Mar 02, 2011 11:49 EST
Nov 17, 2010 08:50 EST
Nov 09, 2011 12:13 EST
Dr. Dahl joined Halo Genomics from Ion Torrent Systems where he served as Senior Scientist and project leader, R&D. He was also Senior Scientist and group leader at Complete Genomics, a California-based DNA sequencing company. Dr. Dahl spent 2 years as a postdoc at Ron Davis lab at Stanford Genome Technology Center and holds a PhD in Molecular Medicine from Uppsala University. Dr. Dahl has...
Prior to joining Halo Genomics, Mrs. Hjortsmark worked as Senior Brand Manager at Phadia AB, a specialty company in allergy and autoimmune disease diagnostics. Maria begun her career at Pharmacia Biotech (now part of GE Healthcare) and has nearly 20 years experience from product management, marketing and sales. She has performed a variety of roles in companies such as Pyrosequencing AB (now...
Dr. Ericsson is President and CEO of Halo Genomics. During his PhD, Dr. Ericsson focused on multiplex detection techniques for nucleic acids and proteins. Dr. Ericsson is author of nine peer-reviewed articles, published in leading journals such as Nature Methods and Nucleic Acids Research. He is also designated inventor of three patents.